Login
Register
Complete Your Profile
Change Password
Request a Password Reset
Download Documents
Download Documents
Get Help to Participate in This Tender
Change Password
For better security, update the account password.
Title/Summary: Tender for Open-House Biologika Discount Contracts 2025-19 for Adalimumab issued by Techniker Krankenkasse in Hamburg, Germany. The contract duration is up to 24 months starting from August 1, 2025, and ending by July 31, 2027.
Scope Of Work: The tender aims to establish discount contracts for the pharmaceutical product Adalimumab under the Open-House Biologika procedure. The involved health insurances will enter into agreements with all suitable pharmaceutical companies without exclusive rights for any partner. No individual negotiations on contract terms will be conducted, and uniform conditions will apply. Additional details are available in the participation and contract documents.
Qualification Criterion: Bidders must be pharmaceutical companies capable of entering into discount contracts as per § 130a Abs. 8 SGB V for Adalimumab. Compliance with the specified regulations and the ability to meet uniform conditions for the contracts are mandatory. Further eligibility criteria and document requirements are outlined in the tender documents.
Purchaser contact is for registered users
Login to see detailsTender details are for registered users
Login to see details| Tender | Country | TOT Ref. No. | Bid deadline |
|---|---|---|---|
| Operation of a Dynamic Procurement System for Laboratory Consumables. | Germany | 152653979 | 02 Jan 2027 |
| Conclusion of Non-Exclusive Discount Agreements in Accordance with Section 130 a Paragraph 8 Sgb V with the Active Ingredient Ustekinumab from January 1, 2027 | Germany | 152653877 | 10 Aug 2028 |
| Open House Biologics Discount Agreements 2026-09 - Etanercept | Germany | 152653671 | 31 Dec 2026 |
| Delivery of Cleaning Products, Anker Facilities, Gu Etc., Government of Lower Bavaria | Germany | 152653374 | 17 Dec 2026 |
| Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for Drugs with the Active Ingredient Tacrolimus (Atc: D11ah01). | Germany | 152653349 | 27 Oct 2028 |